Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The tumor cell membrane, when targeted for photoinduced damage, refers to the plasma membrane of cancer cells that is disrupted or destroyed through photochemical reactions. This process is central to several modern cancer therapies, such as photodynamic therapy (PDT) and near-infrared photoimmunotherapy (NIR-PIT), which use light-activated agents to selectively kill tumor cells by damaging their membranes. Damage is achieved via ROS-mediated lipid/protein oxidation or through disruption of the actin cytoskeleton, leading to osmotic imbalance and cell lysis.
Photoactivation of photosensitizers leading to reactive oxygen species (ROS) generation and subsequent lipid/protein oxidation in the membrane. Alternatively, photoactivation of antibody-photoabsorber conjugates leading to cytoskeletal disruption and membrane rupture.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor Cell Membrane (via Photoinduced Damage).